|
December 14, 2005
AMGEN to Acquire ABGENIX for $22.50 / share
December 20, 2005
Angiotech announces Vascular Wrap(TM)/Lifespan(R) Vascular Graft combination product receives designation of "device" for U.S. pivotal study
December 19, 2005
Angiotech announces new appointments to executive management team
December 12, 2005
AnorMED announces 73% of cancer patients who failed prior chemotherapy mobilizations succeed in collecting enough stem cells for transplant
December 8, 2005
AnorMED Closes $34,500,000 Bought Deal Financing
January 10, 2006
CANTEST BioPharma Services acquires two API 5000™ LC-MS/MS systems
December 9, 2005
Cardiome Initiates Phase 2a Study for Oral RSD1235
January 9, 2006
Chromos Announces Expansion of Pfizer Collaboration
January 12, 2006
Discovery Parks has 12,286 square feet of lab space available at the Don Rix Building, 2389 Health Sciences Mall on the UBC Campus
January 4, 2006
Forbes Medi-Tech Announces Reducol™ Based Products Available Next Week at Tesco Stores Ltd.
December 20, 2005
Forbes Launches Cholesterol-Lowering Ingredient Reducol™ in the UK ~Products Incorporating Reducol™ Destined for UK’s Largest Retailer, Tesco Stores~
December 8, 2005
ID Biomedical announces closing of acquisition by GlaxoSmithKline
January 3, 2006
Inex Files Information Circular for Shareholders Meeting January 26, 2006 to Approve Spin Out of Targeted Immunotherapy Assets
January 5, 2006
Inflazyme Pharmaceuticals Announces New Chairman of Audit Committee
December 20, 2005
Inflazyme Pharmaceuticals Proceeds with Clinical Phase IIb Asthma Study with IPL512,602
December 8, 2005
MIGENIX Completes License Agreement for MX-594AN - Establishes Broad Dermatology Alliance with Cutanea Life Sciences, Inc.
January 16, 2006
Protox receives FDA approval to proceed with Phase I trial
December 14, 2005
Protox files IND with U.S. FDA for prostate cancer
December 7, 2005
QLT Announces Repositioning and Streamlining for Future Growth
January 4, 2006
QSV Biologics, Ltd. and Helix Biopharma Corporation Sign Letter of Intent in Process Development and Manufacture of L-DOS47 Lung Cancer Therapeutic
|
